News
Apr 02, 2026
New results from a clinical trial show promising outcomes for a gene-edited treatment for severe sickle cell disease , a genetic blood disorder with few curative…
Apr 01, 2026
New results from a clinical trial show promising outcomes for a gene-edited treatment for severe sickle cell disease, a genetic blood disorder with few curative…
Apr 01, 2026
AbstractSickle Cell Disease (SCD) remains a public health challenge in India, particularly among tribal populations. Gaps persist in early detection, awareness, and…
Apr 01, 2026
Editas Medicine has reported positive outcomes for a gene editing treatment to treat severe sickle cell disease, a hereditary blood disorder with limited treatment…
Apr 01, 2026
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, group-sequential study (Part A), followed by an open-label LTE period (Part B)…
Apr 01, 2026
Madhya Pradesh Governor Mangubhai Patel, on Tuesday, asserted that the efforts to eliminate Sickle Cell Anaemia and TB (tuberculosis) from the state should be given…
Apr 01, 2026
New results from a clinical trial show promising outcomes for a gene-edited treatment for severe sickle cell disease, a genetic blood disorder with few…
Apr 01, 2026
MERRILLVILLE - Travail With Us founder and CEO Alfreida Robins is once again leading the charge to raise awareness for Sickle Cell disease through two free…
Apr 01, 2026
Sickle cell disease is characterized by chronic hemolytic anemia and recurrent severe vaso-occlusive crises. Ristoglogene autogetemcel (risto-cel) includes…
Apr 01, 2026
New results from a clinical trial show promising outcomes for a gene-edited treatment for severe sickle cell disease, a genetic blood disorder with few curative…